MDL 100240
Alternative Names: 100240; M 100240; MDL100240Latest Information Update: 17 Mar 2009
At a glance
- Originator sanofi-aventis
- Class Antihypertensives; Benzazepines; Carboxylic acids; Heart failure therapies; Small molecules
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension